{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:33:23Z","timestamp":1792510403369,"version":"4.5.0"},"reference-count":236,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,4,16]],"date-time":"2020-04-16T00:00:00Z","timestamp":1586995200000},"content-version":"vor","delay-in-days":381,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunity"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.immuni.2019.03.018","type":"journal-article","created":{"date-parts":[[2019,4,16]],"date-time":"2019-04-16T10:59:57Z","timestamp":1555412397000},"page":"975-991","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1007,"title":["The Cytokines of Asthma"],"prefix":"10.1016","volume":"50","author":[{"given":"Bart N.","family":"Lambrecht","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamida","family":"Hammad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John V.","family":"Fahy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.immuni.2019.03.018_bib1","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1001\/jama.2015.19330","article-title":"Effect of subcutaneous dupilumab on nasal polyp burden in patients with chronic sinusitis and nasal polyposis: a randomized clinical trial","volume":"315","author":"Bachert","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.immuni.2019.03.018_bib2","doi-asserted-by":"crossref","first-page":"eaat9453","DOI":"10.1126\/sciimmunol.aat9453","article-title":"The cysteinyl leukotriene 3 receptor regulates expansion of IL-25-producing airway brush cells leading to type 2 inflammation","volume":"3","author":"Bankova","year":"2018","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.immuni.2019.03.018_bib3","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/s41577-018-0006-6","article-title":"Targeting cytokines to treat asthma and chronic obstructive pulmonary disease","volume":"18","author":"Barnes","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.immuni.2019.03.018_bib4","doi-asserted-by":"crossref","first-page":"174ra26","DOI":"10.1126\/scitranslmed.3004812","article-title":"Lipoxin A4 regulates natural killer cell and type 2 innate lymphoid cell activation in asthma","volume":"5","author":"Barnig","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.immuni.2019.03.018_bib5","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.4049\/jimmunol.1102832","article-title":"IL-33-responsive lineage- CD25+ CD44hi lymphoid cells mediate innate type 2 immunity and allergic inflammation in the lungs","volume":"188","author":"Bartemes","year":"2012","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.immuni.2019.03.018_bib6","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1111\/cea.12988","article-title":"DNA methylation of Th2 lineage determination genes at birth is associated with allergic outcomes in childhood","volume":"47","author":"Barton","year":"2017","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.immuni.2019.03.018_bib7","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1056\/NEJMoa1403291","article-title":"Oral glucocorticoid-sparing effect of mepolizumab in eosinophilic asthma","volume":"371","author":"Bel","year":"2014","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.immuni.2019.03.018_bib8","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/ni.2541","article-title":"The transcription factor STAT5 is critical in dendritic cells for the development of TH2 but not TH1 responses","volume":"14","author":"Bell","year":"2013","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.immuni.2019.03.018_bib9","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/mi.2011.60","article-title":"Interleukin (IL)-4, IL-13, and IL-17A differentially affect the profibrotic and proinflammatory functions of fibrocytes from asthmatic patients","volume":"5","author":"Bellini","year":"2012","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.immuni.2019.03.018_bib10","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1056\/NEJMoa050580","article-title":"Evidence of a role of tumor necrosis factor alpha in refractory asthma","volume":"354","author":"Berry","year":"2006","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.immuni.2019.03.018_bib11","article-title":"CCR10+ ILC2s with ILC1-like properties exhibit a protective function in severe allergic asthma","author":"Beuraud","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.immuni.2019.03.018_bib12","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1164\/rccm.201706-1070OC","article-title":"IFN-stimulated gene expression, type 2 inflammation, and endoplasmic reticulum stress in asthma","volume":"197","author":"Bhakta","year":"2018","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.immuni.2019.03.018_bib13","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.chest.2016.03.032","article-title":"Reslizumab for inadequately controlled asthma with elevated blood eosinophil levels: a randomized phase 3 study","volume":"150","author":"Bjermer","year":"2016","journal-title":"Chest"},{"key":"10.1016\/j.immuni.2019.03.018_bib14","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.jaci.2014.12.1950","article-title":"Coexpression of type 2 immune targets in sputum-derived epithelial and dendritic cells from asthmatic subjects","volume":"136","author":"Bleck","year":"2015","journal-title":"J.\u00a0Allergy Clin. Immunol."},{"key":"10.1016\/j.immuni.2019.03.018_bib15","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/S0140-6736(16)31324-1","article-title":"Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting \u03b22-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial","volume":"388","author":"Bleecker","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.immuni.2019.03.018_bib16","doi-asserted-by":"crossref","first-page":"1800936","DOI":"10.1183\/13993003.00936-2018","article-title":"Baseline patient factors impact on the clinical efficacy of benralizumab for severe asthma","volume":"52","author":"Bleecker","year":"2018","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.immuni.2019.03.018_bib17","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1056\/NEJM199010113231505","article-title":"Eosinophilic inflammation in asthma","volume":"323","author":"Bousquet","year":"1990","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.immuni.2019.03.018_bib18","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/j.1398-9995.2004.00770.x","article-title":"The effect of treatment with omalizumab, an anti-IgE antibody, on asthma exacerbations and emergency medical visits in patients with severe persistent asthma","volume":"60","author":"Bousquet","year":"2005","journal-title":"Allergy"},{"key":"10.1016\/j.immuni.2019.03.018_bib19","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1172\/JCI115366","article-title":"Endobronchial allergen challenge in asthma. Demonstration of cellular source of granulocyte macrophage colony-stimulating factor by in\u00a0situ hybridization","volume":"88","author":"Broide","year":"1991","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.immuni.2019.03.018_bib20","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1165\/ajrcmb.12.3.7873190","article-title":"Allergen-induced airway inflammation and bronchial responsiveness in wild-type and interleukin-4-deficient mice","volume":"12","author":"Brusselle","year":"1995","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.immuni.2019.03.018_bib21","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1164\/rccm.201212-2318OC","article-title":"Randomized, double-blind, placebo-controlled study of brodalumab, a human anti-IL-17 receptor monoclonal antibody, in moderate to severe asthma","volume":"188","author":"Busse","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.immuni.2019.03.018_bib22","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.jaci.2018.08.031","article-title":"Anti-IL-5 treatments in patients with severe asthma by blood eosinophil thresholds: Indirect treatment comparison","volume":"143","author":"Busse","year":"2019","journal-title":"J.\u00a0Allergy Clin. Immunol."},{"key":"10.1016\/j.immuni.2019.03.018_bib23","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S2213-2600(18)30406-5","article-title":"Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial","volume":"7","author":"Busse","year":"2019","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.immuni.2019.03.018_bib24","doi-asserted-by":"crossref","first-page":"1800948","DOI":"10.1183\/13993003.00948-2018","article-title":"Tralokinumab did not demonstrate oral corticosteroid-sparing effects in severe asthma","volume":"53","author":"Busse","year":"2019","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.immuni.2019.03.018_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2015.01.016","article-title":"Pediatric severe asthma with fungal sensitization is mediated by steroid-resistant IL-33","volume":"136","author":"Castanhinha","year":"2015","journal-title":"J.\u00a0Allergy Clin. Immunol."},{"key":"10.1016\/j.immuni.2019.03.018_bib26","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S2213-2600(15)00042-9","article-title":"Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials","volume":"3","author":"Castro","year":"2015","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.immuni.2019.03.018_bib27","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1056\/NEJMoa1804092","article-title":"Dupilumab efficacy and safety in moderate-to-severe uncontrolled asthma","volume":"378","author":"Castro","year":"2018","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.immuni.2019.03.018_bib28","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/s41590-018-0067-5","article-title":"Environmental allergens induce allergic inflammation through proteolytic maturation of IL-33","volume":"19","author":"Cayrol","year":"2018","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.immuni.2019.03.018_bib29","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1126\/sciimmunol.aal5196","article-title":"PPAR-\u03b3 promotes type 2 immune responses in allergy and nematode infection","volume":"2","author":"Chen","year":"2017","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.immuni.2019.03.018_bib30","doi-asserted-by":"crossref","first-page":"301ra129","DOI":"10.1126\/scitranslmed.aab3142","article-title":"TH2 and TH17 inflammatory pathways are reciprocally regulated in asthma","volume":"7","author":"Choy","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.immuni.2019.03.018_bib31","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jaci.2012.08.002","article-title":"IL-33, but not thymic stromal lymphopoietin or IL-25, is central to mite and peanut allergic sensitization","volume":"131","author":"Chu","year":"2013","journal-title":"J.\u00a0Allergy Clin. Immunol."},{"key":"10.1016\/j.immuni.2019.03.018_bib32","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1084\/jem.186.10.1737","article-title":"Induction of airway mucus production By T helper 2 (Th2) cells: a critical role for interleukin 4 in cell recruitment but not mucus production","volume":"186","author":"Cohn","year":"1997","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.immuni.2019.03.018_bib33","doi-asserted-by":"crossref","first-page":"3813","DOI":"10.4049\/jimmunol.161.8.3813","article-title":"IL-4-independent induction of airway hyperresponsiveness by Th2, but not Th1, cells","volume":"161","author":"Cohn","year":"1998","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.immuni.2019.03.018_bib34","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1084\/jem.190.9.1309","article-title":"T helper 1 cells and interferon gamma regulate allergic airway inflammation and mucus production","volume":"190","author":"Cohn","year":"1999","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.immuni.2019.03.018_bib35","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/nm1462","article-title":"Role of deficient type III interferon-lambda production in asthma exacerbations","volume":"12","author":"Contoli","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.immuni.2019.03.018_bib36","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1111\/all.12627","article-title":"Th2 cytokines impair innate immune responses to rhinovirus in respiratory epithelial cells","volume":"70","author":"Contoli","year":"2015","journal-title":"Allergy"},{"key":"10.1016\/j.immuni.2019.03.018_bib37","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1398-9995.2007.01601.x","article-title":"Geohelminth infections: a review of the role of IgE and assessment of potential risks of anti-IgE treatment","volume":"63","author":"Cooper","year":"2008","journal-title":"Allergy"},{"key":"10.1016\/j.immuni.2019.03.018_bib38","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.immuni.2015.07.015","article-title":"Interleukin-21-producing CD4+ T\u00a0cells promote type 2 immunity to house dust mites","volume":"43","author":"Coquet","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2019.03.018_bib39","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1164\/rccm.200909-1448OC","article-title":"A randomized, controlled, phase 2 study of AMG 317, an IL-4Ralpha antagonist, in patients with asthma","volume":"181","author":"Corren","year":"2010","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.immuni.2019.03.018_bib40","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1056\/NEJMoa1106469","article-title":"Lebrikizumab treatment in adults with asthma","volume":"365","author":"Corren","year":"2011","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.immuni.2019.03.018_bib41","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.chest.2016.03.018","article-title":"Phase 3 study of reslizumab in patients with poorly controlled asthma: effects across a broad range of eosinophil counts","volume":"150","author":"Corren","year":"2016","journal-title":"Chest"},{"key":"10.1016\/j.immuni.2019.03.018_bib42","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1056\/NEJMoa1704064","article-title":"Tezepelumab in adults with uncontrolled asthma","volume":"377","author":"Corren","year":"2017","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.immuni.2019.03.018_bib43","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1084\/jem.183.1.109","article-title":"Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity","volume":"183","author":"Corry","year":"1996","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.immuni.2019.03.018_bib44","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.jaci.2014.01.002","article-title":"Efficacy and safety of an anti-IL-13 mAb in patients with severe asthma: a randomized trial","volume":"133","author":"De Boever","year":"2014","journal-title":"J.\u00a0Allergy Clin. Immunol."},{"key":"10.1016\/j.immuni.2019.03.018_bib45","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/j.immuni.2016.10.031","article-title":"Perinatal activation of the interleukin-33 pathway promotes type 2 immunity in the developing lung","volume":"45","author":"de Kleer","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2019.03.018_bib46","first-page":"373","article-title":"Bronchoalveolar eosinophilia during allergen-induced late asthmatic reactions","volume":"131","author":"De Monchy","year":"1985","journal-title":"Am. Rev. Respir. Dis."},{"key":"10.1016\/j.immuni.2019.03.018_bib47","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/s41385-018-0012-9","article-title":"Notch signaling represents an important checkpoint between follicular T-helper and canonical T-helper 2 cell fate","volume":"11","author":"Dell\u2019Aringa","year":"2018","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.immuni.2019.03.018_bib48","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/s41588-017-0014-7","article-title":"Multiancestry association study identifies new asthma risk loci that colocalize with immune-cell enhancer marks","volume":"50","author":"Demenais","year":"2018","journal-title":"Nat. Genet."},{"key":"10.1016\/j.immuni.2019.03.018_bib49","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1164\/rccm.201602-0419OC","article-title":"Inflammatory and comorbid features of patients with severe asthma and frequent exacerbations","volume":"195","author":"Denlinger","year":"2017","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.immuni.2019.03.018_bib50","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.immuni.2015.10.012","article-title":"pulmonary epithelial cell-derived cytokine TGF-\u03b21 is a critical cofactor for enhanced innate lymphoid cell function","volume":"43","author":"Denney","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2019.03.018_bib51","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1164\/rccm.200312-1651OC","article-title":"Effects of treatment with anti-immunoglobulin E antibody omalizumab on airway inflammation in allergic asthma","volume":"170","author":"Djukanovi\u0107","year":"2004","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.immuni.2019.03.018_bib52","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1111\/all.12446","article-title":"Group 2 innate lymphoid cells and CD4+ T\u00a0cells cooperate to mediate type 2 immune response in mice","volume":"69","author":"Drake","year":"2014","journal-title":"Allergy"},{"key":"10.1016\/j.immuni.2019.03.018_bib53","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jaci.2016.09.020","article-title":"House dust mite-driven asthma and allergen-specific T\u00a0cells depend on B cells when the amount of inhaled allergen is limiting","volume":"140","author":"Dullaers","year":"2017","journal-title":"J.\u00a0Allergy Clin. Immunol."},{"issue":"Suppl 2","key":"10.1016\/j.immuni.2019.03.018_bib54","doi-asserted-by":"crossref","first-page":"S144","DOI":"10.1513\/AnnalsATS.201506-377AW","article-title":"the role of type 2 inflammation in the pathogenesis of asthma exacerbations","volume":"12","author":"Dunican","year":"2015","journal-title":"Ann. Am. Thorac. Soc."},{"key":"10.1016\/j.immuni.2019.03.018_bib55","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1172\/JCI95693","article-title":"Mucus plugs in patients with asthma linked to eosinophilia and airflow obstruction","volume":"128","author":"Dunican","year":"2018","journal-title":"J.\u00a0Clin. Invest."},{"issue":"Supplement_3","key":"10.1016\/j.immuni.2019.03.018_bib56","doi-asserted-by":"crossref","first-page":"S184","DOI":"10.1513\/AnnalsATS.201807-485AW","article-title":"Autopsy and imaging studies of mucus in asthma. lessons learned about disease mechanisms and the role of mucus in airflow obstruction","volume":"15","author":"Dunican","year":"2018","journal-title":"Ann. Am. Thorac. Soc."},{"key":"10.1016\/j.immuni.2019.03.018_bib57","doi-asserted-by":"crossref","first-page":"eaam5446","DOI":"10.1126\/sciimmunol.aam5446","article-title":"Natural killer cell-mediated inflammation resolution is disabled in severe asthma","volume":"2","author":"Duvall","year":"2017","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.immuni.2019.03.018_bib58","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jaci.2016.11.023","article-title":"Group 2 innate lymphoid cells are recruited to the nasal mucosa in patients with aspirin-exacerbated respiratory disease","volume":"140","author":"Eastman","year":"2017","journal-title":"J.\u00a0Allergy Clin. Immunol."},{"key":"10.1016\/j.immuni.2019.03.018_bib59","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/mi.2012.118","article-title":"Impaired innate interferon induction in severe therapy resistant atopic asthmatic children","volume":"6","author":"Edwards","year":"2013","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.immuni.2019.03.018_bib60","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.immuni.2015.01.016","article-title":"The interleukin-33-p38 kinase axis confers memory T helper 2 cell pathogenicity in the airway","volume":"42","author":"Endo","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2019.03.018_bib61","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1164\/rccm.201701-0120OC","article-title":"Effects of omalizumab on rhinovirus infections, illnesses, and exacerbations of asthma","volume":"196","author":"Esquivel","year":"2017","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.immuni.2019.03.018_bib62","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nri3786","article-title":"Type 2 inflammation in asthma--present in most, absent in many","volume":"15","author":"Fahy","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.immuni.2019.03.018_bib63","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0091-6749(95)70128-1","article-title":"Prominent neutrophilic inflammation in sputum from subjects with asthma exacerbation","volume":"95","author":"Fahy","year":"1995","journal-title":"J.\u00a0Allergy Clin. Immunol."},{"key":"10.1016\/j.immuni.2019.03.018_bib64","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1164\/ajrccm.155.6.9196082","article-title":"The effect of an anti-IgE monoclonal antibody on the early- and late-phase responses to allergen inhalation in asthmatic subjects","volume":"155","author":"Fahy","year":"1997","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.immuni.2019.03.018_bib65","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1016\/S0140-6736(16)31322-8","article-title":"Benralizumab, an anti-interleukin-5 receptor \u03b1 monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial","volume":"388","author":"FitzGerald","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.immuni.2019.03.018_bib66","doi-asserted-by":"crossref","first-page":"94580","DOI":"10.1172\/jci.insight.94580","article-title":"Severe asthma in humans and mouse model suggests a CXCL10 signature underlies corticosteroid-resistant Th1 bias","volume":"2","author":"Gauthier","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.immuni.2019.03.018_bib67","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1056\/NEJMoa1402895","article-title":"Effects of an anti-TSLP antibody on allergen-induced asthmatic responses","volume":"370","author":"Gauvreau","year":"2014","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.immuni.2019.03.018_bib68","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1084\/jem.182.5.1527","article-title":"Interleukin 12 inhibits antigen-induced airway hyperresponsiveness, inflammation, and Th2 cytokine expression in mice","volume":"182","author":"Gavett","year":"1995","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.immuni.2019.03.018_bib69","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jaci.2012.07.047","article-title":"Omalizumab is effective in allergic and nonallergic patients with nasal polyps and asthma","volume":"131","author":"Gevaert","year":"2013","journal-title":"J.\u00a0Allergy Clin. Immunol."},{"key":"10.1016\/j.immuni.2019.03.018_bib70","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1378\/chest.119.5.1329","article-title":"Heterogeneity of airway inflammation in persistent asthma : evidence of neutrophilic inflammation and increased sputum interleukin-8","volume":"119","author":"Gibson","year":"2001","journal-title":"Chest"},{"key":"10.1016\/j.immuni.2019.03.018_bib71","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1016\/j.jaci.2017.07.035","article-title":"Enhanced plasmacytoid dendritic cell antiviral responses after omalizumab","volume":"141","author":"Gill","year":"2018","journal-title":"J.\u00a0Allergy Clin. Immunol."},{"key":"10.1016\/j.immuni.2019.03.018_bib72","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.jaci.2018.06.002","article-title":"A bispecific antibody strategy to target multiple type 2 cytokines in asthma","volume":"142","author":"Godar","year":"2018","journal-title":"J.\u00a0Allergy Clin. Immunol."},{"key":"10.1016\/j.immuni.2019.03.018_bib73","doi-asserted-by":"crossref","first-page":"e87871","DOI":"10.1172\/jci.insight.87871","article-title":"IL1RL1 asthma risk variants regulate airway type 2 inflammation","volume":"1","author":"Gordon","year":"2016","journal-title":"JCI Insight"},{"key":"10.1016\/j.immuni.2019.03.018_bib74","doi-asserted-by":"crossref","first-page":"8765","DOI":"10.1073\/pnas.1601914113","article-title":"Alternative splicing of interleukin-33 and type 2 inflammation in asthma","volume":"113","author":"Gordon","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2019.03.018_bib75","doi-asserted-by":"crossref","first-page":"1602399","DOI":"10.1183\/13993003.02399-2016","article-title":"Human bronchial epithelium orchestrates dendritic cell activation in severe asthma","volume":"49","author":"Gras","year":"2017","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.immuni.2019.03.018_bib76","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1136\/thoraxjnl-2012-202003","article-title":"IL-25 drives remodelling in allergic airways disease induced by house dust mite","volume":"68","author":"Gregory","year":"2013","journal-title":"Thorax"},{"key":"10.1016\/j.immuni.2019.03.018_bib77","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1126\/science.282.5397.2261","article-title":"Requirement for IL-13 independently of IL-4 in experimental asthma","volume":"282","author":"Gr\u00fcnig","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.immuni.2019.03.018_bib78","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1038\/ni.3244","article-title":"Innate immunological function of TH2 cells in\u00a0vivo","volume":"16","author":"Guo","year":"2015","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.immuni.2019.03.018_bib79","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1056\/NEJMoa0808991","article-title":"Mepolizumab and exacerbations of refractory eosinophilic asthma","volume":"360","author":"Haldar","year":"2009","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.immuni.2019.03.018_bib80","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.immuni.2011.12.020","article-title":"Lung natural helper cells are a critical source of Th2 cell-type cytokines in protease allergen-induced airway inflammation","volume":"36","author":"Halim","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2019.03.018_bib81","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.immuni.2014.01.011","article-title":"Group 2 innate lymphoid cells are critical for the initiation of adaptive T helper 2 cell-mediated allergic lung inflammation","volume":"40","author":"Halim","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2019.03.018_bib82","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/ni.3294","article-title":"Group 2 innate lymphoid cells license dendritic cells to potentiate memory TH2 cell responses","volume":"17","author":"Halim","year":"2016","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.immuni.2019.03.018_bib83","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.immuni.2018.05.003","article-title":"Tissue-restricted adaptive type 2 immunity is orchestrated by expression of the costimulatory molecule OX40L on group 2 innate lymphoid cells","volume":"48","author":"Halim","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2019.03.018_bib84","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/nri2275","article-title":"Dendritic cells and epithelial cells: linking innate and adaptive immunity in asthma","volume":"8","author":"Hammad","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.immuni.2019.03.018_bib85","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.immuni.2015.07.007","article-title":"Barrier epithelial cells and the control of type 2 immunity","volume":"43","author":"Hammad","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2019.03.018_bib86","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/nm.1946","article-title":"House dust mite allergen induces asthma via Toll-like receptor 4 triggering of airway structural cells","volume":"15","author":"Hammad","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.immuni.2019.03.018_bib87","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1084\/jem.20101563","article-title":"Inflammatory dendritic cells--not basophils--are necessary and sufficient for induction of Th2 immunity to inhaled house dust mite allergen","volume":"207","author":"Hammad","year":"2010","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.immuni.2019.03.018_bib88","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S2213-2600(16)30265-X","article-title":"Efficacy and safety of lebrikizumab in patients with uncontrolled asthma (LAVOLTA I and LAVOLTA II): replicate, phase 3, randomised, double-blind, placebo-controlled trials","volume":"4","author":"Hanania","year":"2016","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.immuni.2019.03.018_bib89","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1165\/rcmb.2009-0418OC","article-title":"Thymic stromal lymphopoietin gene promoter polymorphisms are associated with susceptibility to bronchial asthma","volume":"44","author":"Harada","year":"2011","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.immuni.2019.03.018_bib90","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/978-1-4939-6786-5_10","article-title":"Murine models of allergic asthma","volume":"1559","author":"Haspeslagh","year":"2017","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.immuni.2019.03.018_bib91","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1165\/rcmb.2017-0201LE","article-title":"Cytometric gating stringency impacts studies of type 2 innate lymphoid cells in asthma","volume":"57","author":"Hinks","year":"2017","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.immuni.2019.03.018_bib92","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/cea.12462","article-title":"Group 2 innate lymphoid cells (ILC2s) are increased in chronic rhinosinusitis with nasal polyps or eosinophilia","volume":"45","author":"Ho","year":"2015","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.immuni.2019.03.018_bib93","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/icb.1997.43","article-title":"Interleukin-5 and eosinophils induce airway damage and bronchial hyperreactivity during allergic airway inflammation in BALB\/c mice","volume":"75","author":"Hogan","year":"1997","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.immuni.2019.03.018_bib94","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1600-065X.2011.01030.x","article-title":"The sentinel role of the airway epithelium in asthma pathogenesis","volume":"242","author":"Holgate","year":"2011","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.immuni.2019.03.018_bib95","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.immuni.2015.11.004","article-title":"Interleukin-2-dependent allergen-specific tissue-resident memory cells drive asthma","volume":"44","author":"Hondowicz","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2019.03.018_bib96","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/ni.3078","article-title":"IL-25-responsive, lineage-negative KLRG1hi cells are multipotential \u2018inflammatory\u2019 type 2 innate lymphoid cells","volume":"16","author":"Huang","year":"2015","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.immuni.2019.03.018_bib97","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.4049\/jimmunol.1302984","article-title":"IL-33 and thymic stromal lymphopoietin mediate immune pathology in response to chronic airborne allergen exposure","volume":"193","author":"Iijima","year":"2014","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.immuni.2019.03.018_bib98","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.jaci.2014.05.038","article-title":"Increased frequency of dual-positive TH2\/TH17 cells in bronchoalveolar lavage fluid characterizes a population of patients with severe asthma","volume":"134","author":"Irvin","year":"2014","journal-title":"J.\u00a0Allergy Clin. Immunol."},{"key":"10.1016\/j.immuni.2019.03.018_bib99","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1164\/rccm.201406-1039OC","article-title":"IL-33-dependent type 2 inflammation during rhinovirus-induced asthma exacerbations in\u00a0vivo","volume":"190","author":"Jackson","year":"2014","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.immuni.2019.03.018_bib100","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1183\/09031936.00124912","article-title":"Airway and systemic inflammation in obese children with asthma","volume":"42","author":"Jensen","year":"2013","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.immuni.2019.03.018_bib101","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.jaci.2012.06.025","article-title":"Periostin is a systemic biomarker of eosinophilic airway inflammation in asthmatic patients","volume":"130","author":"Jia","year":"2012","journal-title":"J.\u00a0Allergy Clin. Immunol."},{"key":"10.1016\/j.immuni.2019.03.018_bib102","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1038\/ncomms3675","article-title":"Thymic stromal lymphopoietin induces corticosteroid resistance in natural helper cells during airway inflammation","volume":"4","author":"Kabata","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.immuni.2019.03.018_bib103","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1164\/rccm.200909-1462OC","article-title":"IL-9 governs allergen-induced mast cell numbers in the lung and chronic remodeling of the airways","volume":"183","author":"Kearley","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.immuni.2019.03.018_bib104","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1164\/rccm.201609-1830OC","article-title":"Role for NLRP3 inflammasome-mediated, IL-1\u03b2-dependent responses in severe, steroid-resistant asthma","volume":"196","author":"Kim","year":"2017","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.immuni.2019.03.018_bib105","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1002\/eji.201142018","article-title":"Pulmonary innate lymphoid cells are major producers of IL-5 and IL-13 in murine models of allergic asthma","volume":"42","author":"Klein Wolterink","year":"2012","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.immuni.2019.03.018_bib106","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.jaci.2018.03.019","article-title":"Solitary chemosensory cells are a primary epithelial source of IL-25 in patients with chronic rhinosinusitis with nasal polyps","volume":"142","author":"Kohanski","year":"2018","journal-title":"J.\u00a0Allergy Clin. Immunol."},{"key":"10.1016\/j.immuni.2019.03.018_bib107","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.jaci.2010.04.004","article-title":"MEDI-563, a humanized anti-IL-5 receptor alpha mAb with enhanced antibody-dependent cell-mediated cytotoxicity function","volume":"125","author":"Kolbeck","year":"2010","journal-title":"J.\u00a0Allergy Clin. Immunol."},{"key":"10.1016\/j.immuni.2019.03.018_bib108","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.immuni.2011.03.015","article-title":"An unexpected role for uric acid as an inducer of T helper 2 cell immunity to inhaled antigens and inflammatory mediator of allergic asthma","volume":"34","author":"Kool","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2019.03.018_bib109","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1126\/sciimmunol.aao4747","article-title":"Neutrophil cytoplasts induce TH17 differentiation and skew inflammation toward neutrophilia in severe asthma","volume":"3","author":"Krishnamoorthy","year":"2018","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.immuni.2019.03.018_bib110","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1056\/NEJMoa1411776","article-title":"Allergen-induced asthmatic responses modified by a GATA3-specific DNAzyme","volume":"372","author":"Krug","year":"2015","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.immuni.2019.03.018_bib111","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/nm.2684","article-title":"IL-17A produced by \u03b1\u03b2 T\u00a0cells drives airway hyper-responsiveness in mice and enhances mouse and human airway smooth muscle contraction","volume":"18","author":"Kudo","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.immuni.2019.03.018_bib112","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1165\/ajrcmb.13.3.7654390","article-title":"Involvement of IL-5 in a murine model of allergic pulmonary inflammation: prophylactic and therapeutic effect of an anti-IL-5 antibody","volume":"13","author":"Kung","year":"1995","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.immuni.2019.03.018_bib113","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/cea.12179","article-title":"Frequent exacerbators--a distinct phenotype of severe asthma","volume":"44","author":"Kupczyk","year":"2014","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.immuni.2019.03.018_bib114","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1084\/jem.187.6.939","article-title":"Signal transducer and activator of transcription factor 6 (Stat6)-deficient mice are protected from antigen-induced airway hyperresponsiveness and mucus production","volume":"187","author":"Kuperman","year":"1998","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.immuni.2019.03.018_bib115","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/nm.2737","article-title":"The airway epithelium in asthma","volume":"18","author":"Lambrecht","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.immuni.2019.03.018_bib116","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/ni.3049","article-title":"The immunology of asthma","volume":"16","author":"Lambrecht","year":"2015","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.immuni.2019.03.018_bib117","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1038\/ni.3829","article-title":"The immunology of the allergy epidemic and the hygiene hypothesis","volume":"18","author":"Lambrecht","year":"2017","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.immuni.2019.03.018_bib118","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.jaci.2013.05.020","article-title":"Effects of benralizumab on airway eosinophils in asthmatic patients with sputum eosinophilia","volume":"132","author":"Laviolette","year":"2013","journal-title":"J.\u00a0Allergy Clin. Immunol."},{"key":"10.1016\/j.immuni.2019.03.018_bib119","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1016\/S0140-6736(00)03496-6","article-title":"Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response","volume":"356","author":"Leckie","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.immuni.2019.03.018_bib120","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.jaci.2011.06.041","article-title":"Short ragweed pollen triggers allergic inflammation through Toll-like receptor 4-dependent thymic stromal lymphopoietin\/OX40 ligand\/OX40 signaling pathways","volume":"128","author":"Li","year":"2011","journal-title":"J.\u00a0Allergy Clin. Immunol."},{"key":"10.1016\/j.immuni.2019.03.018_bib121","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1002\/eji.201546119","article-title":"T cells are necessary for ILC2 activation in house dust mite-induced allergic airway inflammation in mice","volume":"46","author":"Li","year":"2016","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.immuni.2019.03.018_bib122","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/ni.2182","article-title":"Divergent expression patterns of IL-4 and IL-13 define unique functions in allergic immunity","volume":"13","author":"Liang","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.immuni.2019.03.018_bib123","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.cyto.2018.07.004","article-title":"Genetic variants in RORA are associated with asthma and allergy markers in an admixed population","volume":"113","author":"Lima","year":"2019","journal-title":"Cytokine"},{"key":"10.1016\/j.immuni.2019.03.018_bib124","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/S0002-9343(02)01047-1","article-title":"Association of forced expiratory volume with disease duration and sputum neutrophils in chronic asthma","volume":"112","author":"Little","year":"2002","journal-title":"Am. J. Med."},{"key":"10.1016\/j.immuni.2019.03.018_bib125","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jaci.2017.03.032","article-title":"Steroid resistance of airway type 2 innate lymphoid cells from patients with severe asthma: The role of thymic stromal lymphopoietin","volume":"141","author":"Liu","year":"2018","journal-title":"J.\u00a0Allergy Clin. Immunol."},{"key":"10.1016\/j.immuni.2019.03.018_bib126","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.jaci.2014.02.007","article-title":"Incidence of malignancy in patients with moderate-to-severe asthma treated with or without omalizumab","volume":"134","author":"Long","year":"2014","journal-title":"J.\u00a0Allergy Clin. Immunol."},{"key":"10.1016\/j.immuni.2019.03.018_bib127","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1038\/s41385-018-0057-9","article-title":"Dynamics of helper CD4 T\u00a0cells during acute and stable allergic asthma","volume":"11","author":"Lu","year":"2018","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.immuni.2019.03.018_bib128","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1038\/mi.2014.8","article-title":"The complex relationship between inflammation and lung function in severe asthma","volume":"7","author":"Manni","year":"2014","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.immuni.2019.03.018_bib129","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2017.09.050","article-title":"Cytokine-induced endogenous production of prostaglandin D2 is essential for human group 2 innate lymphoid cell activation","author":"Maric","year":"2018","journal-title":"J.\u00a0Allergy Clin. Immunol."},{"key":"10.1016\/j.immuni.2019.03.018_bib130","first-page":"A6165","article-title":"On-demand inhaled interferon-beta 1a for the prevention of severe asthma exacerbations: results of the INEXAS phase 2a study","volume":"197","author":"McCrae","year":"2018","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.immuni.2019.03.018_bib131","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1164\/rccm.201109-1640OC","article-title":"A large subgroup of mild-to-moderate asthma is persistently noneosinophilic","volume":"185","author":"McGrath","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.immuni.2019.03.018_bib132","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1126\/science.1240342","article-title":"Cleavage of fibrinogen by proteinases elicits allergic responses through Toll-like receptor 4","volume":"341","author":"Millien","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.immuni.2019.03.018_bib133","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/ni.2104","article-title":"Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161","volume":"12","author":"Mj\u00f6sberg","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.immuni.2019.03.018_bib134","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.immuni.2012.08.015","article-title":"The transcription factor GATA3 is essential for the function of human type 2 innate lymphoid cells","volume":"37","author":"Mj\u00f6sberg","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2019.03.018_bib135","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/mi.2015.59","article-title":"Group 2 innate lymphoid cells utilize the IRF4-IL-9 module to coordinate epithelial cell maintenance of lung homeostasis","volume":"9","author":"Mohapatra","year":"2016","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.immuni.2019.03.018_bib136","doi-asserted-by":"crossref","first-page":"e007709","DOI":"10.1136\/bmjopen-2015-007709","article-title":"Phase 2, randomised placebo-controlled trial to evaluate the efficacy and safety of an anti-GM-CSF antibody (KB003) in patients with inadequately controlled asthma","volume":"6","author":"Molfino","year":"2016","journal-title":"BMJ Open"},{"key":"10.1016\/j.immuni.2019.03.018_bib137","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/s41586-018-0393-7","article-title":"A revised airway epithelial hierarchy includes CFTR-expressing ionocytes","volume":"560","author":"Montoro","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2019.03.018_bib138","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.immuni.2018.06.009","article-title":"Airway epithelial cell-derived colony stimulating factor-1 promotes allergen sensitization","volume":"49","author":"Moon","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2019.03.018_bib139","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1164\/rccm.200906-0896OC","article-title":"Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program","volume":"181","author":"Moore","year":"2010","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.immuni.2019.03.018_bib140","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2013.10.011","article-title":"Sputum neutrophil counts are associated with more severe asthma phenotypes using cluster analysis","volume":"133","author":"Moore","year":"2014","journal-title":"J.\u00a0Allergy Clin. Immunol."},{"key":"10.1016\/j.immuni.2019.03.018_bib141","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1136\/thx.2007.086314","article-title":"The role of a soluble TNF\u03b1 receptor fusion protein (etanercept) in corticosteroid refractory asthma: a double blind, randomised, placebo controlled trial","volume":"63","author":"Morjaria","year":"2008","journal-title":"Thorax"},{"key":"10.1016\/j.immuni.2019.03.018_bib142","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.immuni.2014.04.013","article-title":"Basophil-derived interleukin-4 controls the function of natural helper cells, a member of ILC2s, in lung inflammation","volume":"40","author":"Motomura","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2019.03.018_bib143","doi-asserted-by":"crossref","first-page":"e1006925","DOI":"10.1371\/journal.pgen.1006925","article-title":"Rare coding variants pinpoint genes that control human hematological traits","volume":"13","author":"Mousas","year":"2017","journal-title":"PLoS Genet."},{"key":"10.1016\/j.immuni.2019.03.018_bib144","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1056\/NEJMoa0805435","article-title":"Mepolizumab for prednisone-dependent asthma with sputum eosinophilia","volume":"360","author":"Nair","year":"2009","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.immuni.2019.03.018_bib145","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1056\/NEJMoa1703501","article-title":"Oral Glucocorticoid-Sparing Effect of Benralizumab in Severe Asthma","volume":"376","author":"Nair","year":"2017","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.immuni.2019.03.018_bib146","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1084\/jem.179.4.1145","article-title":"Role of vascular cell adhesion molecule 1\/very late activation antigen 4 and intercellular adhesion molecule 1\/lymphocyte function-associated antigen 1 interactions in antigen-induced eosinophil and T\u00a0cell recruitment into the tissue","volume":"179","author":"Nakajima","year":"1994","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.immuni.2019.03.018_bib147","article-title":"Tuft cells-systemically dispersed sensory epithelia integrating immune and neural circuitry","author":"O\u2019Leary","year":"2018","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.immuni.2019.03.018_bib148","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1111\/all.12705","article-title":"T cells are the critical source of IL-4\/IL-13 in a mouse model of allergic asthma","volume":"70","author":"Oeser","year":"2015","journal-title":"Allergy"},{"key":"10.1016\/j.immuni.2019.03.018_bib149","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/ni.3447","article-title":"IL-1 is a critical regulator of group 2 innate lymphoid cell function and plasticity","volume":"17","author":"Ohne","year":"2016","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.immuni.2019.03.018_bib150","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.immuni.2010.08.011","article-title":"Basophils orchestrate chronic allergic dermatitis and protective immunity against helminths","volume":"33","author":"Ohnmacht","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2019.03.018_bib151","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.immuni.2014.06.016","article-title":"MHCII-mediated dialog between group 2 innate lymphoid cells and CD4+ T\u00a0cells potentiates type 2 immunity and promotes parasitic helminth expulsion","volume":"41","author":"Oliphant","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2019.03.018_bib152","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1164\/ajrccm.161.4.9812061","article-title":"Increased neutrophil numbers and IL-8 levels in airway secretions in acute severe asthma: Clinical and biologic significance","volume":"161","author":"Ordo\u00f1ez","year":"2000","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.immuni.2019.03.018_bib153","doi-asserted-by":"crossref","first-page":"91019","DOI":"10.1172\/jci.insight.91019","article-title":"IRF5 distinguishes severe asthma in humans and drives Th1 phenotype and airway hyperreactivity in mice","volume":"2","author":"Oriss","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.immuni.2019.03.018_bib154","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1056\/NEJMoa1403290","article-title":"Mepolizumab treatment in patients with severe eosinophilic asthma","volume":"371","author":"Ortega","year":"2014","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.immuni.2019.03.018_bib155","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S2213-2600(16)30031-5","article-title":"Severe eosinophilic asthma treated with mepolizumab stratified by baseline eosinophil thresholds: a secondary analysis of the DREAM and MENSA studies","volume":"4","author":"Ortega","year":"2016","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.immuni.2019.03.018_bib156","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S2213-2600(18)30184-X","article-title":"Tralokinumab for severe, uncontrolled asthma (STRATOS 1 and STRATOS 2): two randomised, double-blind, placebo-controlled, phase 3 clinical trials","volume":"6","author":"Panettieri","year":"2018","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.immuni.2019.03.018_bib157","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.jaci.2006.06.004","article-title":"IL-4 induces IL-13-independent allergic airway inflammation","volume":"118","author":"Perkins","year":"2006","journal-title":"J.\u00a0Allergy Clin. Immunol."},{"key":"10.1016\/j.immuni.2019.03.018_bib158","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.jaci.2015.02.026","article-title":"Transcriptome analysis of controlled and therapy-resistant childhood asthma reveals distinct gene expression profiles","volume":"136","author":"Persson","year":"2015","journal-title":"J.\u00a0Allergy Clin. Immunol."},{"key":"10.1016\/j.immuni.2019.03.018_bib159","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1183\/13993003.01132-2016","article-title":"Metabolic consequences of obesity as an \u201coutside in\u201d mechanism of disease severity in asthma","volume":"48","author":"Peters","year":"2016","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.immuni.2019.03.018_bib160","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/S2213-2600(16)30048-0","article-title":"Plasma interleukin-6 concentrations, metabolic dysfunction, and asthma severity: a cross-sectional analysis of two cohorts","volume":"4","author":"Peters","year":"2016","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.immuni.2019.03.018_bib161","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jaci.2017.12.1009","article-title":"Refractory airway type 2 inflammation in a large subgroup of asthmatic patients treated with inhaled corticosteroids","volume":"143","author":"Peters","year":"2019","journal-title":"J.\u00a0Allergy Clin. Immunol."},{"key":"10.1016\/j.immuni.2019.03.018_bib162","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1164\/rccm.201807-1291OC","article-title":"A transcriptomic method to determine airway immune dysfunction in T2-high and T2-low asthma","volume":"199","author":"Peters","year":"2019","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.immuni.2019.03.018_bib163","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.immuni.2012.10.016","article-title":"Conventional and monocyte-derived CD11b(+) dendritic cells initiate and maintain T helper 2 cell-mediated immunity to house dust mite allergen","volume":"38","author":"Plantinga","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2019.03.018_bib164","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1056\/NEJMoa1804093","article-title":"Efficacy and safety of dupilumab in glucocorticoid-dependent severe asthma","volume":"378","author":"Rabe","year":"2018","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.immuni.2019.03.018_bib165","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.jaci.2016.08.026","article-title":"Combined blockade of the IL-13 and IL-33 pathways leads to a greater inhibition of type 2 inflammation over inhibition of either pathway alone","volume":"139","author":"Ramirez-Carrozzi","year":"2017","journal-title":"J.\u00a0Allergy Clin. Immunol."},{"key":"10.1016\/j.immuni.2019.03.018_bib166","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1172\/JCI80911","article-title":"High IFN-\u03b3 and low SLPI mark severe asthma in mice and humans","volume":"125","author":"Raundhal","year":"2015","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.immuni.2019.03.018_bib167","article-title":"IL-33 drives influenza-induced asthma exacerbations by halting innate and adaptive antiviral immunity","author":"Ravanetti","year":"2018","journal-title":"J.\u00a0Allergy Clin. Immunol."},{"key":"10.1016\/j.immuni.2019.03.018_bib168","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.it.2017.07.003","article-title":"Neutrophilic inflammation in asthma and association with disease severity","volume":"38","author":"Ray","year":"2017","journal-title":"Trends Immunol."},{"key":"10.1016\/j.immuni.2019.03.018_bib169","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1165\/rcmb.2002-0207OC","article-title":"Interleukin-9 induces mucous cell metaplasia independent of inflammation","volume":"28","author":"Reader","year":"2003","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.immuni.2019.03.018_bib170","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/nature05746","article-title":"Chitin induces accumulation in tissue of innate immune cells associated with allergy","volume":"447","author":"Reese","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2019.03.018_bib171","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/s41590-018-0201-4","article-title":"Tissue signals imprint ILC2 identity with anticipatory function","volume":"19","author":"Ricardo-Gonzalez","year":"2018","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.immuni.2019.03.018_bib172","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.immuni.2019.03.018_bib173","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/S0140-6736(17)32247-X","article-title":"Effect of interleukin-1\u03b2 inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial","volume":"390","author":"Ridker","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.immuni.2019.03.018_bib174","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S1471-4906(02)02278-0","article-title":"On the generation of allergic airway diseases: from GM-CSF to Kyoto","volume":"23","author":"Ritz","year":"2002","journal-title":"Trends Immunol."},{"key":"10.1016\/j.immuni.2019.03.018_bib175","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1056\/NEJM199201303260504","article-title":"Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma","volume":"326","author":"Robinson","year":"1992","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.immuni.2019.03.018_bib176","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1126\/scisignal.aam8858","article-title":"TSLP signaling in CD4+ T\u00a0cells programs a pathogenic T helper 2 cell state","volume":"11","author":"Rochman","year":"2018","journal-title":"Sci. Signal."},{"key":"10.1016\/j.immuni.2019.03.018_bib177","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/j.jaci.2015.03.043","article-title":"IL-2 is a critical regulator of group 2 innate lymphoid cell function during pulmonary inflammation","volume":"136","author":"Roediger","year":"2015","journal-title":"J.\u00a0Allergy Clin. Immunol."},{"key":"10.1016\/j.immuni.2019.03.018_bib178","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S2213-2600(18)30201-7","article-title":"Effect of tralokinumab, an interleukin-13 neutralising monoclonal antibody, on eosinophilic airway inflammation in uncontrolled moderate-to-severe asthma (MESOS): a multicentre, double-blind, randomised, placebo-controlled phase 2 trial","volume":"6","author":"Russell","year":"2018","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.immuni.2019.03.018_bib179","doi-asserted-by":"crossref","first-page":"eaan4128","DOI":"10.1126\/sciimmunol.aan4128","article-title":"Inception of early-life allergen-induced airway hyperresponsiveness is reliant on IL-13+CD4+ T\u00a0cells","volume":"3","author":"Saglani","year":"2018","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.immuni.2019.03.018_bib180","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.jaci.2016.12.958","article-title":"Cysteinyl leukotriene E4 activates human group 2 innate lymphoid cells and enhances the effect of prostaglandin D2 and epithelial cytokines","volume":"140","author":"Salimi","year":"2017","journal-title":"J.\u00a0Allergy Clin. Immunol."},{"key":"10.1016\/j.immuni.2019.03.018_bib181","doi-asserted-by":"crossref","first-page":"164","DOI":"10.4049\/jimmunol.1003392","article-title":"High-affinity IgE receptors on dendritic cells exacerbate Th2-dependent inflammation","volume":"187","author":"Sallmann","year":"2011","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.immuni.2019.03.018_bib182","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1084\/jem.20061401","article-title":"Interleukin-17 is a negative regulator of established allergic asthma","volume":"203","author":"Schnyder-Candrian","year":"2006","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.immuni.2019.03.018_bib183","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1126\/science.aac6623","article-title":"Farm dust and endotoxin protect against allergy through A20 induction in lung epithelial cells","volume":"349","author":"Schuijs","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.immuni.2019.03.018_bib184","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.it.2018.11.001","article-title":"Professional and \u2018amateur\u2019 antigen-presenting cells in type 2 immunity","volume":"40","author":"Schuijs","year":"2019","journal-title":"Trends Immunol."},{"key":"10.1016\/j.immuni.2019.03.018_bib185","doi-asserted-by":"crossref","first-page":"3868","DOI":"10.1172\/JCI33559","article-title":"In\u00a0vivo blockade of OX40 ligand inhibits thymic stromal lymphopoietin driven atopic inflammation","volume":"117","author":"Seshasayee","year":"2007","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.immuni.2019.03.018_bib186","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/ni.2937","article-title":"Epigenomic analysis of primary human T\u00a0cells reveals enhancers associated with TH2 memory cell differentiation and asthma susceptibility","volume":"15","author":"Seumois","year":"2014","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.immuni.2019.03.018_bib187","doi-asserted-by":"crossref","first-page":"7134","DOI":"10.4049\/jimmunol.0902515","article-title":"Thymic stromal lymphopoietin receptor-mediated IL-6 and CC\/CXC chemokines expression in human airway smooth muscle cells: role of MAPKs (ERK1\/2, p38, and JNK) and STAT3 pathways","volume":"184","author":"Shan","year":"2010","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.immuni.2019.03.018_bib188","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2011.08.031","article-title":"Increased expression of immunoreactive thymic stromal lymphopoietin in patients with severe asthma","volume":"129","author":"Shikotra","year":"2012","journal-title":"J.\u00a0Allergy Clin. Immunol."},{"key":"10.1016\/j.immuni.2019.03.018_bib189","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/ni.3443","article-title":"Inflammatory triggers associated with exacerbations of COPD orchestrate plasticity of group 2 innate lymphoid cells in the lungs","volume":"17","author":"Silver","year":"2016","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.immuni.2019.03.018_bib190","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1056\/NEJMoa1610020","article-title":"Two phase 3 trials of dupilumab versus placebo in atopic dermatitis","volume":"375","author":"Simpson","year":"2016","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.immuni.2019.03.018_bib191","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1038\/s41467-018-04574-1","article-title":"Corticosteroid suppression of antiviral immunity increases bacterial loads and mucus production in COPD exacerbations","volume":"9","author":"Singanayagam","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.immuni.2019.03.018_bib192","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.immuni.2013.09.016","article-title":"Thymic stromal lymphopoietin-mediated extramedullary hematopoiesis promotes allergic inflammation","volume":"39","author":"Siracusa","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2019.03.018_bib193","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1056\/NEJMoa0901867","article-title":"Variants of DENND1B associated with asthma in children","volume":"362","author":"Sleiman","year":"2010","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.immuni.2019.03.018_bib194","doi-asserted-by":"crossref","first-page":"e1006659","DOI":"10.1371\/journal.pgen.1006659","article-title":"A\u00a0rare IL33 loss-of-function mutation reduces blood eosinophil counts and protects from asthma","volume":"13","author":"Smith","year":"2017","journal-title":"PLoS Genet."},{"key":"10.1016\/j.immuni.2019.03.018_bib195","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/ni1558","article-title":"A mechanism for the initiation of allergen-induced T helper type 2 responses","volume":"9","author":"Sokol","year":"2008","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.immuni.2019.03.018_bib196","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jaci.2017.02.038","article-title":"Type 2 innate lymphoid cells disrupt bronchial epithelial barrier integrity by targeting tight junctions through IL-13 in asthmatic patients","volume":"141","author":"Sugita","year":"2018","journal-title":"J.\u00a0Allergy Clin. Immunol."},{"key":"10.1016\/j.immuni.2019.03.018_bib197","doi-asserted-by":"crossref","first-page":"6393","DOI":"10.1126\/science.aan8546","article-title":"Pulmonary neuroendocrine cells amplify allergic asthma responses","volume":"360","author":"Sui","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.immuni.2019.03.018_bib198","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1016\/j.jaci.2012.03.044","article-title":"Rhinovirus 16-induced IFN-\u03b1 and IFN-\u03b2 are deficient in bronchoalveolar lavage cells in asthmatic patients","volume":"129","author":"Sykes","year":"2012","journal-title":"J.\u00a0Allergy Clin. Immunol."},{"key":"10.1016\/j.immuni.2019.03.018_bib199","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1136\/thoraxjnl-2012-202909","article-title":"Rhinovirus-induced interferon production is not deficient in well controlled asthma","volume":"69","author":"Sykes","year":"2014","journal-title":"Thorax"},{"key":"10.1016\/j.immuni.2019.03.018_bib200","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/j.jaci.2015.09.008","article-title":"Preseasonal treatment with either omalizumab or an inhaled corticosteroid boost to prevent fall asthma exacerbations","volume":"136","author":"Teach","year":"2015","journal-title":"J.\u00a0Allergy Clin. Immunol."},{"key":"10.1016\/j.immuni.2019.03.018_bib201","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.jaip.2017.05.032","article-title":"baseline features of the severe asthma research program (SARP III) cohort: differences with age","volume":"6","author":"Teague","year":"2018","journal-title":"J.\u00a0Allergy Clin. Immunol. Pract."},{"key":"10.1016\/j.immuni.2019.03.018_bib202","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0140-6736(15)00388-8","article-title":"Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial","volume":"387","author":"Tha\u00e7i","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.immuni.2019.03.018_bib203","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.immuni.2014.02.003","article-title":"Chitin activates parallel immune modules that direct distinct inflammatory responses via innate lymphoid type 2 and \u03b3\u03b4 T\u00a0cells","volume":"40","author":"Van Dyken","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2019.03.018_bib204","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1038\/ni.3582","article-title":"A tissue checkpoint regulates type 2 immunity","volume":"17","author":"Van Dyken","year":"2016","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.immuni.2019.03.018_bib205","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jaci.2004.03.044","article-title":"Essential role of dendritic cell CD80\/CD86 costimulation in the induction, but not reactivation, of TH2 effector responses in a mouse model of asthma","volume":"114","author":"van Rijt","year":"2004","journal-title":"J.\u00a0Allergy Clin. Immunol."},{"key":"10.1016\/j.immuni.2019.03.018_bib206","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.jaci.2017.10.020","article-title":"Experimental asthma persists in IL-33 receptor knockout mice because of the emergence of thymic stromal lymphopoietin-driven IL-9+ and IL-13+ type 2 innate lymphoid cell subpopulations","volume":"142","author":"Verma","year":"2018","journal-title":"J.\u00a0Allergy Clin. Immunol."},{"key":"10.1016\/j.immuni.2019.03.018_bib207","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/nsmb.2794","article-title":"Structural basis of the proinflammatory signaling complex mediated by TSLP","volume":"21","author":"Verstraete","year":"2014","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.immuni.2019.03.018_bib208","doi-asserted-by":"crossref","first-page":"14937","DOI":"10.1038\/ncomms14937","article-title":"Structure and antagonism of the receptor complex mediated by human TSLP in allergy and asthma","volume":"8","author":"Verstraete","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.immuni.2019.03.018_bib209","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2147\/JAA.S15081","article-title":"Clinical update on the use of biomarkers of airway inflammation in the management of asthma","volume":"4","author":"Wadsworth","year":"2011","journal-title":"J.\u00a0Asthma Allergy"},{"key":"10.1016\/j.immuni.2019.03.018_bib210","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1164\/rccm.200801-086OC","article-title":"IL-23 and Th17 cells enhance Th2-cell-mediated eosinophilic airway inflammation in mice","volume":"178","author":"Wakashin","year":"2008","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.immuni.2019.03.018_bib211","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.clim.2014.09.007","article-title":"Increased ILC2s in the eosinophilic nasal polyp endotype are associated with corticosteroid responsiveness","volume":"155","author":"Walford","year":"2014","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.immuni.2019.03.018_bib212","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.4049\/jimmunol.146.6.1829","article-title":"T cell subsets and their soluble products regulate eosinophilia in allergic and nonallergic asthma","volume":"146","author":"Walker","year":"1991","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.immuni.2019.03.018_bib213","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/nature24029","article-title":"The neuropeptide NMU amplifies ILC2-driven allergic lung inflammation","volume":"549","author":"Wallrapp","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2019.03.018_bib214","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.4049\/jimmunol.1800709","article-title":"bronchial allergen challenge of patients with atopic asthma triggers an alarmin (IL-33, TSLP, and IL-25) response in the airways epithelium and submucosa","volume":"201","author":"Wang","year":"2018","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.immuni.2019.03.018_bib215","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1084\/jem.20041901","article-title":"Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus","volume":"201","author":"Wark","year":"2005","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.immuni.2019.03.018_bib216","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jaip.2018.08.021","article-title":"Effects of reslizumab on asthma outcomes in a subgroup of eosinophilic asthma patients with self-reported chronic rhinosinusitis with nasal polyps","volume":"7","author":"Weinstein","year":"2019","journal-title":"J.\u00a0Allergy Clin. Immunol. Pract."},{"key":"10.1016\/j.immuni.2019.03.018_bib217","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/nm.2678","article-title":"Asthma phenotypes: the evolution from clinical to molecular approaches","volume":"18","author":"Wenzel","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.immuni.2019.03.018_bib218","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1164\/ajrccm.160.3.9812110","article-title":"Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics","volume":"160","author":"Wenzel","year":"1999","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.immuni.2019.03.018_bib219","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1164\/rccm.200607-909OC","article-title":"IL4R alpha mutations are associated with asthma exacerbations and mast cell\/IgE expression","volume":"175","author":"Wenzel","year":"2007","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.immuni.2019.03.018_bib220","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1164\/rccm.200809-1512OC","article-title":"A randomized, double-blind, placebo-controlled study of tumor necrosis factor-alpha blockade in severe persistent asthma","volume":"179","author":"Wenzel","year":"2009","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.immuni.2019.03.018_bib221","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1056\/NEJMoa1304048","article-title":"Dupilumab in persistent asthma with elevated eosinophil levels","volume":"368","author":"Wenzel","year":"2013","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.immuni.2019.03.018_bib222","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(16)30307-5","article-title":"Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting \u03b22 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial","volume":"388","author":"Wenzel","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.immuni.2019.03.018_bib223","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1084\/jem.20112691","article-title":"Interleukin-1\u03b1 controls allergic sensitization to inhaled house dust mite via the epithelial release of GM-CSF and IL-33","volume":"209","author":"Willart","year":"2012","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.immuni.2019.03.018_bib224","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1084\/jem.192.3.455","article-title":"Mast cells can amplify airway reactivity and features of chronic inflammation in an asthma model in mice","volume":"192","author":"Williams","year":"2000","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.immuni.2019.03.018_bib225","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1126\/science.282.5397.2258","article-title":"Interleukin-13: central mediator of allergic asthma","volume":"282","author":"Wills-Karp","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.immuni.2019.03.018_bib226","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2019.01.027","article-title":"Activation of Group 2 innate lymphoid cells after allergen challenge in asthmatics","author":"Winkler","year":"2019","journal-title":"J.\u00a0Allergy Clin. Immunol."},{"key":"10.1016\/j.immuni.2019.03.018_bib227","doi-asserted-by":"crossref","first-page":"15858","DOI":"10.1073\/pnas.0707413104","article-title":"Genome-wide profiling identifies epithelial cell genes associated with asthma and with treatment response to corticosteroids","volume":"104","author":"Woodruff","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2019.03.018_bib228","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1164\/rccm.200903-0392OC","article-title":"T-helper type 2-driven inflammation defines major subphenotypes of asthma","volume":"180","author":"Woodruff","year":"2009","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.immuni.2019.03.018_bib229","first-page":"1167","article-title":"Multiview cluster analysis identifies variable corticosteroid response phenotypes in severe asthma","volume":"139","author":"Wu","year":"2019","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.immuni.2019.03.018_bib230","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.jaci.2013.10.056","article-title":"Prostaglandin D2 activates group 2 innate lymphoid cells through chemoattractant receptor-homologous molecule expressed on TH2 cells","volume":"133","author":"Xue","year":"2014","journal-title":"J.\u00a0Allergy Clin. Immunol."},{"key":"10.1016\/j.immuni.2019.03.018_bib231","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.jaci.2016.08.008","article-title":"Meta-analysis of asthma-related hospitalization in mepolizumab studies of severe eosinophilic asthma","volume":"139","author":"Yancey","year":"2017","journal-title":"J.\u00a0Allergy Clin. Immunol."},{"key":"10.1016\/j.immuni.2019.03.018_bib232","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jaci.2015.01.025","article-title":"DNA methylation and childhood asthma in the inner city","volume":"136","author":"Yang","year":"2015","journal-title":"J.\u00a0Allergy Clin. Immunol."},{"key":"10.1016\/j.immuni.2019.03.018_bib233","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.cell.2015.11.052","article-title":"Regulation of T-cell receptor internalization by DENND1B in Th2 cells and allergic disease","volume":"164","author":"Yang","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2019.03.018_bib234","doi-asserted-by":"crossref","first-page":"8183","DOI":"10.4049\/jimmunol.174.12.8183","article-title":"Thymic stromal lymphopoietin expression is increased in asthmatic airways and correlates with expression of Th2-attracting chemokines and disease severity","volume":"174","author":"Ying","year":"2005","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.immuni.2019.03.018_bib235","doi-asserted-by":"crossref","first-page":"e0133490","DOI":"10.1371\/journal.pone.0133490","article-title":"Asthma is more severe in older adults","volume":"10","author":"Zein","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.immuni.2019.03.018_bib236","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/mi.2012.76","article-title":"Th17 responses in chronic allergic airway inflammation abrogate regulatory T-cell-mediated tolerance and contribute to airway remodeling","volume":"6","author":"Zhao","year":"2012","journal-title":"Mucosal Immunol."}],"container-title":["Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1074761319301359?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1074761319301359?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T08:06:36Z","timestamp":1761033996000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1074761319301359"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":236,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S1074761319301359"],"URL":"https:\/\/doi.org\/10.1016\/j.immuni.2019.03.018","relation":{},"ISSN":["1074-7613"],"issn-type":[{"value":"1074-7613","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Cytokines of Asthma","name":"articletitle","label":"Article Title"},{"value":"Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.immuni.2019.03.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}